KENNETH K WU, M.D.
Osteopathic Medicine at Fannin St, Houston, TX
License number
Texas G7027
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Texas G7027
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
6410 Fannin St, Houston, TX 77030
Phone
(713) 704-3961
(713) 500-3500
(713) 500-5484 (Fax)
(713) 500-3500
(713) 500-5484 (Fax)
Personal information
See more information about KENNETH K WU at radaris.comName
Address
Phone
5000 Montrose Blvd UNIT 10E, Houston, TX 77006
3700 Cole Ave APT 315, Dallas, TX 75204
6106 Briar Terrace Dr, Houston, TX 77072
14206 Briarworth Dr, Houston, TX 77077
11125 S Country Squire St, Houston, TX 77024
Professional information
Compounds Inhibiting Cox-2 And Inos Promoter Activities
US Patent:
6969532, Nov 29, 2005
Filed:
Jul 31, 2001
Appl. No.:
09/920121
Inventors:
Kenneth K. Wu - Houston TX, US
International Classification:
C12N005/00
US Classification:
424572, 424520, 435325, 435366, 435190, 514 1
Abstract:
A new chemical compound for treating human inflammatory diseases, tissue damage, stroke, septic shock and cancer. This chemical compound is produced from a process including the following steps: (a) washing human foreskin fibroblasts with a fresh DMEM medium then incubated in a fresh medium containing 2. 5%-10% fetal bovine serum for at least 8 hours to form a proliferating phase medium (PPM); (b) subjecting the proliferating phase medium to a 10-kDa ultrafiltration membrane to separate the proliferating phase medium into a 10 kDa fraction, which is retained by the 10-kDa ultrafiltration membrane; (c) Chromatographing the
Dr. Kenneth K Wu, Houston TX - MD (Doctor of Medicine)
Address:
6431 Fannin St SUITE 5016, Houston 77030
(713) 500-6801 (Phone), (713) 500-6812 (Fax)
6410 Fannin St SUITE 230, Houston 77030
(713) 704-3961 (Phone)
(713) 500-6801 (Phone), (713) 500-6812 (Fax)
6410 Fannin St SUITE 230, Houston 77030
(713) 704-3961 (Phone)
Hospitals:
6431 Fannin St SUITE 5016, Houston 77030
6410 Fannin St SUITE 230, Houston 77030
6410 Fannin St SUITE 230, Houston 77030
Education:
Medical Schools
College of Medicine / National Taiwan University
College of Medicine / National Taiwan University
Dr. Kenneth Q Wu, Chicago IL - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Age:
42
Address:
1653 W Congress Pkwy, Chicago 60612
(312) 942-5000 (Phone), (312) 942-3145 (Fax)
6206 Bankside Dr, Houston 77096
RUSH UNIVERSITY MEDICAL CENTER
1750 W Harrison St SUITE 739, Chicago 60612
(312) 942-6504 (Phone), (312) 942-8858 (Fax)
(312) 942-5000 (Phone), (312) 942-3145 (Fax)
6206 Bankside Dr, Houston 77096
RUSH UNIVERSITY MEDICAL CENTER
1750 W Harrison St SUITE 739, Chicago 60612
(312) 942-6504 (Phone), (312) 942-8858 (Fax)
Languages:
English
Kenneth Kun-Yu Wu, Houston TX
Specialties:
Internal Medicine, Hematology, Hematology & Oncology
Work:
U T Med School
6431 Fannin Pathology, Houston, TX 77030
6431 Fannin Pathology, Houston, TX 77030
Education:
National Taiwan University (1966)
Peroxisome Proliferator-Activator Receptor Δ (Pparδ) And The Development Of Preimplantation Embryos
US Patent:
8632452, Jan 21, 2014
Filed:
Oct 12, 2006
Appl. No.:
12/090060
Inventors:
Alfred W-S Wun - Houston TX, US
Jennifer S. Goldsby - Houston TX, US
Kenneth Wu - Houston TX, US
Jennifer S. Goldsby - Houston TX, US
Kenneth Wu - Houston TX, US
Assignee:
Board of Regents of the University of Texas System - Austin TX
International Classification:
A61B 17/43, C12N 5/06
US Classification:
600 35, 435375, 435404
Abstract:
Methods and compositions for enhancing development of a preimplantation mammalian embryo and for increasing the live birth potential of an in vitro fertilized mammalian embryo are disclosed. An in vitro method of activating the peroxisome proliferator activated receptor δ (PPARδ) in a preimplantation mammalian embryo comprises culturing an embryo in an embryo culture medium, and upon or after commencement of expression of PPARδ in the cells of the embryo, activating the PPARδ by adding an amount of a PPARδ ligand to said medium effective to bind to PPARδ to deter apoptosis in the cells of the cultured embryo and/or increase proliferation of the cells of the cultured embryo.
Vectors, Compositions And Methods For Treating A Vascular Disorder
US Patent:
2002016, Nov 14, 2002
Filed:
Mar 8, 2002
Appl. No.:
10/094210
Inventors:
Kenneth Wu - Houston TX, US
International Classification:
C12P007/40, C12N009/02, C12N015/867, C12N015/861, A61K048/00
US Classification:
435/189000, 435/456000, 435/320100, 435/136000, 514/044000
Abstract:
The present invention discloses vectors comprising a cyclooxygenase sequence, a prostaglandin synthase sequence or both. The invention further discloses methods of making such vectors, and compositions comprising such vectors. Methods for treating a patient afflicted with a vascular disorder by use of said vectors and compositions are also disclosed.